EMPD
Empery Digital Inc.
There isn't enough reported data to score EMPD yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
EMPD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
EMPD's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
EMPD PE Valuation
EMPD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 51x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
EMPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect EMPD to return to profit, with revenue declining.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
EMPD Earnings Per Share
EMPD has the edge over LCID in the latest year-over-year earnings comparison.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
EMPD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $99.6K | -50% |
| Q2 2026 | $80K | -89% |
| Q1 2026 | $225.7K | -69% |
| Q3 2025 | $198.3K | -82% |
| Q2 2025 | $702.9K | -25% |
| Q1 2025 | $736K | -29% |
| Q4 2024 | $986.9K | -8.9% |
| Q3 2024 | $1.1M | +121% |
EMPD's revenue has slid since its 2022 peak: $99,606 last quarter, down 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24458% | +41847 points |
| Q2 2026 | -52573% | -52022 points |
| Q1 2026 | -36912% | -36572 points |
| Q3 2025 | -17389% | -16261 points |
| Q2 2025 | -551% | +37 points |
| Q1 2025 | -341% | +70 points |
| Q4 2024 | -517% | +395 points |
| Q3 2024 | -1128% | +812 points |
EMPD has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over EMPD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
EMPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -$7.3M |
| Q2 2026 | -$6.9M | -$3.2M |
| Q1 2026 | -$3.5M | +$251.5K |
| Q4 2025 | -$3M | +$807.6K |
| Q3 2025 | -$7.6M | -$3.5M |
| Q2 2025 | -$3.7M | +$118.8K |
| Q1 2025 | -$3.8M | +$899.3K |
| Q4 2024 | -$3.8M | +$9.1M |
EMPD has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
EMPD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.2% | +1.7M shares |
| 1 year | -18% | -6.3M shares |
| 3 years | +186313150% | +29.8M shares |
EMPD has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $9.8M |
| Q1 2026 | $44.2M |
| Q4 2025 | $56.9M |
| Q3 2025 | $38.9M |
| Q2 2025 | $109,101 |
| Q1 2025 | $401,806 |
EMPD spent $111M buying back its own shares over the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
EMPD Net Leverage
EMPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EMPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.3 | Oversold |
| Stochastic | 8.5 | Oversold |
EMPD's weekly RSI is 23 (oversold) and its Stochastic is 8 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
EMPD PE vs Consumer Cyclical Sector
EMPD has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
EMPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 24% below |
| 20 week MA | $3.00 | 32% below |
| 50 week MA | $3.83 | 47% below |
| 100 week MA | $7.20 | 72% below |
| 200 week MA | $280,582.3 | 100% below |
EMPD is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
EMPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $13,147,200.0 | $12,297,600.0 | -6.5% |
| 2022 | $12,297,600.0 | $1,339,200.0 | -89% |
| 2023 | $1,339,200.0 | $28,512.0 | -98% |
| 2024 | $28,512.0 | $32.2 | -100% |
| 2025 | $32.2 | $4.35 | -87% |
| 2026 YTD | $4.35 | $2.03 | -53% |
EMPD has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.